UPXI
UPXI
Upexi, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $4.56M ▼ | $10.06M ▼ | $-109.34M ▲ | -2.4K% ▼ | $-1.67 ▲ | $-105.55M ▲ |
| Q2-2026 | $8.05M ▼ | $15.66M ▲ | $-178.92M ▼ | -2.22K% ▼ | $-2.94 ▼ | $-175.17M ▼ |
| Q1-2026 | $9.24M ▲ | $-60.87M ▼ | $66.75M ▲ | 722.4% ▲ | $1.21 ▲ | $69.6M ▲ |
| Q4-2025 | $4.29M ▲ | $9.91M ▲ | $-6.93M ▼ | -161.48% ▼ | $-0.25 ▲ | $-6.57M ▼ |
| Q3-2025 | $3.16M | $5.15M | $-3.83M | -121.24% | $-2.87 | $-3.64M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $118.43M ▲ | $200.37M ▼ | $252.29M ▲ | $-51.92M ▼ |
| Q2-2026 | $1.62M ▼ | $271.14M ▼ | $222.43M ▲ | $48.72M ▼ |
| Q1-2026 | $2.24M ▼ | $419.73M ▲ | $208.94M ▲ | $210.79M ▲ |
| Q4-2025 | $2.98M ▲ | $123.81M ▲ | $33.71M ▲ | $90.1M ▲ |
| Q3-2025 | $230.39K | $15.07M | $13.22M | $1.85M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $-109.34M ▲ | $-4.78M ▼ | $7.88M ▲ | $-1.24M ▼ | $1.87M ▲ | $-4.79M ▼ |
| Q2-2026 | $-178.92M ▼ | $4.95M ▲ | $-6.49M ▲ | $920.21K ▼ | $-620.46K ▲ | $4.96M ▲ |
| Q1-2026 | $66.75M ▲ | $-17.41M ▼ | $-30.34M ▲ | $47.02M ▼ | $-737.93K ▼ | $-17.42M ▼ |
| Q4-2025 | $-6.93M ▼ | $-4.29M ▼ | $-105.05M ▼ | $112.08M ▲ | $2.74M ▲ | $-4.48M ▼ |
| Q3-2025 | $-3.83M | $-778.71K | $-80.59K | $683.34K | $-175.96K | $-809.3K |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Upexi, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include strong gross margins that suggest decent product-level economics, a demonstrated ability to raise capital and expand its asset and equity base, and a differentiated hybrid strategy that combines e-commerce capabilities with a pioneering Solana treasury model. The company’s experience in digital marketing and direct-to-consumer channels, along with early-mover status in offering Solana exposure through a public stock, provides a unique platform that could be leveraged if execution improves. Recent balance sheet strengthening and improved liquidity, following substantial capital infusions, give Upexi some breathing room to pursue its strategy.
Main concerns center on sustained operating losses, worsening free cash flow, and dependence on external financing. Overhead costs have outgrown revenue, leading to deep negative margins and cumulative retained losses. Cash burn has intensified, funded by large equity issuance and additional debt, which introduces dilution and leverage risk. Strategically, the company faces competitive pressures in its consumer categories, regulatory uncertainty in cannabinoids and crypto, and concentrated exposure to the volatility of the Solana ecosystem. The dramatic growth in less transparent asset categories also raises questions about asset quality and sustainability.
The outlook is highly uncertain and sensitive to execution. If Upexi can right-size its cost structure, stabilize or regrow its consumer brand revenue, and successfully implement a more disciplined, risk-managed Solana treasury strategy, its unique positioning could translate into improved profitability and cash generation over time. Conversely, if operating losses persist, free cash flow remains deeply negative, or crypto markets and regulations move against its Solana focus, the company may face continued financial strain despite its enlarged balance sheet. Overall, Upexi appears to be in a transition phase with significant upside and downside paths, and future results will hinge on effective cost control, strategic clarity, and prudent risk management across both sides of its hybrid business.
About Upexi, Inc.
https://www.upexi.comUpexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $4.56M ▼ | $10.06M ▼ | $-109.34M ▲ | -2.4K% ▼ | $-1.67 ▲ | $-105.55M ▲ |
| Q2-2026 | $8.05M ▼ | $15.66M ▲ | $-178.92M ▼ | -2.22K% ▼ | $-2.94 ▼ | $-175.17M ▼ |
| Q1-2026 | $9.24M ▲ | $-60.87M ▼ | $66.75M ▲ | 722.4% ▲ | $1.21 ▲ | $69.6M ▲ |
| Q4-2025 | $4.29M ▲ | $9.91M ▲ | $-6.93M ▼ | -161.48% ▼ | $-0.25 ▲ | $-6.57M ▼ |
| Q3-2025 | $3.16M | $5.15M | $-3.83M | -121.24% | $-2.87 | $-3.64M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $118.43M ▲ | $200.37M ▼ | $252.29M ▲ | $-51.92M ▼ |
| Q2-2026 | $1.62M ▼ | $271.14M ▼ | $222.43M ▲ | $48.72M ▼ |
| Q1-2026 | $2.24M ▼ | $419.73M ▲ | $208.94M ▲ | $210.79M ▲ |
| Q4-2025 | $2.98M ▲ | $123.81M ▲ | $33.71M ▲ | $90.1M ▲ |
| Q3-2025 | $230.39K | $15.07M | $13.22M | $1.85M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $-109.34M ▲ | $-4.78M ▼ | $7.88M ▲ | $-1.24M ▼ | $1.87M ▲ | $-4.79M ▼ |
| Q2-2026 | $-178.92M ▼ | $4.95M ▲ | $-6.49M ▲ | $920.21K ▼ | $-620.46K ▲ | $4.96M ▲ |
| Q1-2026 | $66.75M ▲ | $-17.41M ▼ | $-30.34M ▲ | $47.02M ▼ | $-737.93K ▼ | $-17.42M ▼ |
| Q4-2025 | $-6.93M ▼ | $-4.29M ▼ | $-105.05M ▼ | $112.08M ▲ | $2.74M ▲ | $-4.48M ▼ |
| Q3-2025 | $-3.83M | $-778.71K | $-80.59K | $683.34K | $-175.96K | $-809.3K |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Upexi, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include strong gross margins that suggest decent product-level economics, a demonstrated ability to raise capital and expand its asset and equity base, and a differentiated hybrid strategy that combines e-commerce capabilities with a pioneering Solana treasury model. The company’s experience in digital marketing and direct-to-consumer channels, along with early-mover status in offering Solana exposure through a public stock, provides a unique platform that could be leveraged if execution improves. Recent balance sheet strengthening and improved liquidity, following substantial capital infusions, give Upexi some breathing room to pursue its strategy.
Main concerns center on sustained operating losses, worsening free cash flow, and dependence on external financing. Overhead costs have outgrown revenue, leading to deep negative margins and cumulative retained losses. Cash burn has intensified, funded by large equity issuance and additional debt, which introduces dilution and leverage risk. Strategically, the company faces competitive pressures in its consumer categories, regulatory uncertainty in cannabinoids and crypto, and concentrated exposure to the volatility of the Solana ecosystem. The dramatic growth in less transparent asset categories also raises questions about asset quality and sustainability.
The outlook is highly uncertain and sensitive to execution. If Upexi can right-size its cost structure, stabilize or regrow its consumer brand revenue, and successfully implement a more disciplined, risk-managed Solana treasury strategy, its unique positioning could translate into improved profitability and cash generation over time. Conversely, if operating losses persist, free cash flow remains deeply negative, or crypto markets and regulations move against its Solana focus, the company may face continued financial strain despite its enlarged balance sheet. Overall, Upexi appears to be in a transition phase with significant upside and downside paths, and future results will hinge on effective cost control, strategic clarity, and prudent risk management across both sides of its hybrid business.

CEO
Allan J. Marshall
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-10-03 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
POLAR ASSET MANAGEMENT PARTNERS INC.
Shares:5M
Value:$4.35M
MAREX GROUP PLC
Shares:2.51M
Value:$2.18M
MMCAP INTERNATIONAL INC. SPC
Shares:2.33M
Value:$2.02M
Summary
Showing Top 3 of 99

